中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 1
Jan.  2014
Turn off MathJax
Article Contents

Efficacy and safety of interferon plus ribavirin in elderly patients with chronic hepatitis C: report of 4 cases

DOI: 10.3969/j.issn.1001-5256.2014.01.019
  • Published Date: 2014-01-20
  • loading
  • [1]LI MR, SUN XL, REN GF, et al.Clinical oloservation of pegylated interferon alpha-2a combined voith ribavirin in the treatment of chronic hepatitis C[J].Int J Virol, 2013, 20 (1) :22-23. (in Chinese) 李敏然, 孙杏丽, 任桂芳, 等.聚乙二醇干扰素α-2a联合利巴韦林治疗慢性丙型肝炎的临床观察[J].国际病毒学杂志, 2013, 20 (1) :22-23.
    [2]CAO JJ, XUE BY.Study on traditional Chinese medicine treatment of hepatic C[J].J Changchun Univ Tradit Chin Med, 2012, 28 (2) :71-73. (in Chinese) 曹静静, 薛博瑜.中医药治疗丙型肝炎的研究[J].长春中医药大学学报, 2012, 28 (2) :71-73.
    [3]WANG XF, CHENG YQ, ZHANG WJ, et al.Course analysis:from HCV infection to hepatocellular carcinoma[J].Chin Hepatol, 2004, 9 (1) :8-10. (in Chinese) 王晓峰, 程勇前, 张文瑾, 等.丙型肝炎病毒感染至临床诊断肝癌的病程经过[J].肝脏, 2004, 9 (1) :8-10.
    [4]MIKI D, AIKATA H, UKA K, et al.Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma[J].J Gastroenterol, 2008, 43 (7) :550-557.
    [5]HONDA T, KATANO Y, SHIMIZU J, et al.Efficacy of peginterferon-α-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis[J].Liver Int, 2010, 30 (4) :527-537.
    [6]LIU XM, DUAN ZH, WANG KF, et al.Analysis of effect factors of antiviral therapy outcome for 60 cases of elder hepaitits C patients[J/CD].Chin J Clin:Elentronic Edition, 2012, 6 (10) :2648-2651. (in Chinese) 刘雪梅, 段忠辉, 王克菲, 等.老年丙型肝炎患者60例抗病毒疗效影响因素分析[J/CD].中华临床医师杂志:电子版, 2012, 6 (10) :2648-2651.
    [7]ZHENG YY, FAN XH, WANG LF, et al.Efficacy and side effect of PEG-IFNα-2a plus ribavirin on elderly patients with chronic hepatitis C[J].J Clin Hepatol, 2011, 27 (8) :821-823. (in Chinese) 郑颖颖, 范晓红, 王力芬, 等.聚乙二醇干扰素α-2a联合利巴韦林治疗老年慢性丙型肝炎的疗效和安全性[J].临床肝胆病杂志, 2011, 27 (8) :821-823.
    [8]YAN Q, NA LL, WANG Y.Low-dose interferon incremental solutions in the treatment of 10 cases of elder patients with chronic hepatitis C[J].Harbin Med J, 2009, 29 (1) :15. (in Chinese) 严勤, 那琳琳, 王莹.小剂量干扰素递增方案治疗10例老年慢性丙型肝炎[J].哈尔滨医药, 2009, 29 (1) :15.
    [9]CHENG YQ, QING S, DING N, et al.Introduction of typical cases of HCV infection in elder patients and adjustment of antiviral treatment strategies[J].J Clin Hepatol, 2012, 15 (5) :459-460. (in Chinese) 程勇前, 卿松, 丁宁, 等.老年HCV感染典型病例介绍及抗病毒治疗策略调整[J].实用肝脏病杂志, 2012, 15 (5) :459-460.
    [10]JIANG XQ, ZOU XJ, TIAN DY.Virological response of chronic hepatitis C treated with peg-interferonα-2a and ribavirin[J].J Clin Hepatol, 2011, 27 (4) :417-419. (in Chinese) 姜雪强, 邹小静, 田德英.聚乙二醇干扰素α-2a联合利巴韦林治疗慢性丙型肝炎患者的病毒学应答[J].临床肝胆病杂志, 2011, 27 (4) :417-419.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2917) PDF downloads(620) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return